Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Artra GroupTSE:6029 +0.54%57 Graham Number is 円183.90 as of Jun. 2026. GuruFocus rates TSE:6029 with a GF Score™ of 57/100 and a GF Value™ of 円115.71 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 375 Healthcare Providers & Services companies, Artra Group ranks better than 74.67% on this metric.
Graham Number is a figure that measures a stock's fundamental value by taking into account the company's earnings per share and book value per share. The Graham number is the upper bound of the price range that a defensive investor should pay for the stock. According to the theory, any stock price below the Graham number is considered undervalued, and thus worth investing in.
As of today (2026-09-11), the stock price of Artra Group is 円186.00. Artra Group's graham number for the quarter that ended in Jun. 2026 was 円183.90. Therefore, Artra Group's Price to Graham Number ratio for today is 0.84.
The historical rank and industry rank for Artra Group's Graham Number or its related term are showing as below:
TSE:6029'
s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.66 Med: 1.94 Max: 5.15
Current: 1.01
During the past 13 years, the highest Price to Graham Number ratio of Artra Group was 5.15. The lowest was 0.66. And the median was 1.94.
TSE:6029's Price-to-Graham-Number is ranked better than 74.67% of 375
companies
in the Healthcare Providers & Services industry
Industry Median: 1.61
vs TSE:6029: 1.01
Graham Number is a combination of asset valuation and earnings power valuation. It is a very conservative way of valuing a stock.
Ben Graham actually did not publish a formula like this. But he wrote in The Intelligent Investor (1948 version) regarding to the criteria for purchases:
Current price should not be more than 15 times average earnings of the past three years.
Current price should not be more than 1.5 times the book value last reported. However, a multiplier of earnings below 15 could justify a correspondingly higher multiplier of assets. As a rule of thumb we suggest that the product of the multiplier times the ratio of price to book value should not exceed 22.5. (This figure corresponds to 15 times earnings and 1.5 times book value. It would admit an issue selling at only 9 times earnings and 2.5 times asset value, etc.)
Unlike valuation methods such as DCF or Discounted Earnings, the Graham number does not take growth into the valuation. Unlike the valuation methods based on book value alone, it takes into account the earnings power. Therefore, the Graham Number is a combination of asset valuation and earnings power valuation.
In general, the Graham number is a very conservative way of valuing a stock. It cannot be applied to companies with negative book values.
Artra Group's Price to Graham number Ratio for today is calculated as
Price to Graham number
=
Share Price (Today)
/
Graham number (Q: Jun. 2026 )
=
186.00
/
222.20
=
0.84
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Please keep these in mind:
1. Graham Number does not take growth into account. Therefore it underestimates the values of the companies that have good earnings growth. We feel that if the earnings per share grows more than 10% a year, Graham Number underestimates the value.
2. Graham Number punishes the companies that have temporarily low earnings. Therefore, an average of earnings makes more sense in the calculation of Graham Number.
3. Graham Numbers underestimates companies that are light with book.
Artra Group Graham Number Related Terms
Artra Group Graham Number Historical Data
* Premium members only.
The historical data trend for Artra Group's Graham Number can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6029 vs HCA, THC, EHC: Graham Number Comparison
For the Medical Care Facilities subindustry, Artra Group's Price-to-Graham-Number, along with its competitors' market caps and Price-to-Graham-Number data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Artra Group Price-to-Graham-Number vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Artra Group's Price-to-Graham-Number distribution charts can be found below:
* The bar in red indicates where Artra Group's Price-to-Graham-Number falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Artra Group (TSE:6029) has a Graham Number of 円183.90 as of Jun. 2026. The Graham Number values a company based on its per-share earnings and book value. View historical data on Artra Group and its competitors. According to the industry distribution chart, Artra Group ranks #95 out of 375 companies in the Healthcare Providers & Services industry, placing it in the top 25.3%.
Is Artra Group's Graham Number too high?
Artra Group's current Graham Number is 円183.90. Based on the distribution chart, Artra Group ranks #95 out of 375 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Artra Group has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Artra Group's Graham Number compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Artra Group ranks #95 out of 375 companies for Graham Number. This puts Artra Group in the upper half of its industry. The industry median Graham Number is 1.61. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Graham Number for a Healthcare Providers & Services company?
The median Graham Number among Healthcare Providers & Services companies is 1.61, based on 375 companies in the industry. Companies in the top quartile (top 25%) have a Graham Number significantly above this median, while those in the bottom quartile fall well below. However, Graham Number should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Graham Number mean?
A high Graham Number can signal that a stock is expensive relative to its fundamentals. The Graham Number values a company based on its per-share earnings and book value. View historical data on Artra Group and its competitors. For the Healthcare Providers & Services industry, the median Graham Number is 1.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Artra Group's current Graham Number is 円183.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artra Group stock overvalued right now?
Based on GuruFocus' analysis, Artra Group (TSE:6029) is currently considered Significantly Overvalued. The stock's GF Value™ is 円115.71, compared to a current price of 円186.00 — trading 60.7% above its estimated fair value. The current Graham Number is 円183.90. Artra Group's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Graham Number calculated?
Graham Number is calculated from a company's financial statements. For Artra Group (TSE:6029), the current Graham Number is 円183.90 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Artra Group (TSE:6029) Overvalued in 2026?
Based on GuruFocus' analysis, Artra Group stock appears to be overvalued.
The current stock price of 円186.00 is trading 60.7% above its estimated GF Value™ of 円115.71.
GuruFocus considers Artra Group to be Significantly Overvalued.
Key valuation signals for TSE:6029:
Graham Number: 円183.90
GF Value™: 円115.71 vs. price of 円186.00 (60.7% above fair value)
No single metric tells the full story. See the TSE:6029 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Artra Group Corp is engaged in the healthcare support business, providing services that assist the operation and management of clinics and related facilities. The group has two reportable segments: Acupuncture & Orthopedic Clinic Support and Toy Sales Business. The Acupuncture and Orthopedic Clinic Support segment is involved in supporting acupuncture and orthopedic clinics through services such as bone setting chains, provision of equipment and consumables, Attra billing services, HONEY-STYLE, and nursing care support. The Toy Sales segment focuses on the sale of toys, stationery, and other related products.
57GF Score
Get the complete analysis for TSE:6029
Graham Number is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6029 has been successfully added to your 
